Cross Country Healthcare (CCRN) Stock Forecast, Price Target & Predictions
CCRN Stock Forecast
Cross Country Healthcare (CCRN) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $10.61, with a high of $14.00 and a low of $8.65. This represents a 10.29% increase from the last price of $9.62.
CCRN Stock Rating
Cross Country Healthcare stock's rating consensus is Hold, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (23.08%), 10 Hold (76.92%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Hold
CCRN Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Cross Country Healthcare | 10.29% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Medical Care Facilities Stocks | 21.19% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 3 | 6 |
| Avg Price Target | $14.00 | $11.67 | $10.61 |
| Last Closing Price | $9.62 | $9.62 | $9.62 |
| Upside/Downside | 45.53% | 21.31% | 10.29% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Mar, 26 | 1 | - | 8 | - | - | 9 |
| Feb, 26 | 1 | - | 7 | - | - | 8 |
| Jan, 26 | 1 | - | 7 | - | - | 8 |
| Dec, 25 | - | - | 7 | - | - | 7 |
| Nov, 25 | - | - | 7 | - | - | 7 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Mar 05, 2026 | Bill Sutherland | Cross Research | $14.00 | $9.68 | 44.63% | 45.53% |
| Feb 03, 2026 | Wedbush | $11.00 | $9.29 | 18.41% | 14.35% | |
| Dec 16, 2025 | Truist Financial | $10.00 | $8.17 | 22.40% | 3.95% | |
| Dec 09, 2025 | UBS | $9.00 | $8.14 | 10.57% | -6.44% | |
| Dec 04, 2025 | Jack Slevin | Jefferies | $8.65 | $7.46 | 15.95% | -10.08% |
| Dec 04, 2025 | Constantine Davides | JMP Securities | $11.00 | $7.46 | 47.45% | 14.35% |
| May 06, 2024 | Kevin Steinke | Barrington | $21.00 | $16.58 | 26.66% | 118.30% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Feb 03, 2026 | Wedbush | Neutral | initialise | |
| Dec 19, 2025 | Citigroup | Market Outperform | Market Outperform | hold |
| Dec 09, 2025 | UBS | Neutral | Neutral | hold |
| Dec 08, 2025 | Benchmark | Hold | Hold | hold |
| Dec 04, 2025 | Jefferies | Hold | Hold | hold |
| Dec 04, 2025 | Citigroup | Outperform | upgrade | |
| Nov 14, 2025 | Benchmark | Hold | Hold | hold |
| Aug 08, 2023 | Credit Suisse | Neutral | Neutral | hold |
| Jun 13, 2022 | Benchmark | Buy | Buy | hold |
| Feb 24, 2022 | Benchmark | Buy | Buy | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | |
|---|---|---|---|---|---|---|
| Reported | $3.60 | $5.09 | $2.07 | $-0.44 | $-2.93 | - |
| Avg Forecast | $2.91 | $5.07 | $2.20 | $0.53 | $0.57 | $0.68 |
| High Forecast | $2.97 | $5.27 | $2.23 | $0.54 | $0.76 | $0.76 |
| Low Forecast | $2.84 | $4.89 | $2.18 | $0.51 | $0.40 | $0.59 |
| Surprise % | 23.71% | 0.39% | -5.91% | -183.02% | -614.04% | - |
Revenue Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | |
|---|---|---|---|---|---|---|
| Reported | $1.68B | $2.80B | $2.02B | $1.34B | $1.05B | - |
| Avg Forecast | $1.65B | $2.77B | $2.01B | $1.34B | $1.25B | $1.29B |
| High Forecast | $1.68B | $2.86B | $2.10B | $1.40B | $1.31B | $1.29B |
| Low Forecast | $1.62B | $2.70B | $1.93B | $1.29B | $1.20B | $1.29B |
| Surprise % | 1.54% | 1.10% | 0.48% | 0.28% | -15.89% | - |
Net Income Forecast
Annual
| Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | |
|---|---|---|---|---|---|---|
| Reported | $132.00M | $185.98M | $72.63M | $-14.56M | $-94.85M | - |
| Avg Forecast | $111.59M | $197.02M | $72.63M | $18.72M | $17.88M | $22.56M |
| High Forecast | $133.91M | $236.42M | $87.16M | $19.25M | $27.03M | $27.03M |
| Low Forecast | $89.27M | $157.62M | $58.10M | $18.18M | $14.27M | $20.90M |
| Surprise % | 18.29% | -5.60% | - | -177.77% | -630.44% | - |